Phase III clinical trial - Pédiatrie Neuroblastomes
HR-NBL2
Pédiatrie Neuroblastomes
Ouvert depuis le: 07.27.2024
Site: Paris
Public cible
Enfant
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
Description de l'essai
This is an international multicenter, open-label, randomized phase III trial including three sequential randomizations to assess efficacy of induction and consolidation chemotherapies and radiotherapy for patients with high-risk neuroblastoma.
Liens utiles
![GUDRUN SCHLEIERMACHER Vignette](/sites/default/files/styles/carre_petit/public/annuaire/00970067-612fa93860071.jpg?h=98c429b1&itok=86l3a4UL)
GUDRUN SCHLEIERMACHER
Investigateur principal